The Future of Natural Killer Cell Immunotherapy for B Cell Non-Hodgkin Lymphoma (B Cell NHL)
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1534-6277
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
The Future of Natural Killer Cell Immunotherapy for B Cell Non-Hodgkin Lymphoma (B Cell NHL) ; volume:23 ; number:3 ; day:8 ; month:3 ; year:2022 ; pages:381-403 ; date:3.2022
Current treatment options in oncology ; 23, Heft 3 (8.3.2022), 381-403, 3.2022
- Urheber
-
Chu, Yaya
Lamb, Margaret
Cairo, Mitchell S.
Lee, Dean A.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s11864-021-00932-2
- URN
-
urn:nbn:de:101:1-2022060920021386328272
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:33 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Chu, Yaya
- Lamb, Margaret
- Cairo, Mitchell S.
- Lee, Dean A.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Cytokine expression in B-cell non-Hodgkin lymphomas
Current immunotherapeutic approaches in T cell non-Hodgkin lymphomas
NHL-2007 - familial predisposition for non-Hodgkin lymphomas in childhood and adolescence
NHL-2007 - familial predisposition for non-Hodgkin lymphomas in childhood and adolescence
Harnessing natural killer cells for refractory/relapsed non-Hodgkin lymphoma: biological roles, clinical trials, and future prospective
Absence of annexin I expression in B-cell non-Hodgkin's lymphomas and cell lines
Advances in chimeric antigen receptor T-cell therapy for B-cell non-Hodgkin lymphoma
Front-Line Treatment of High Grade B Cell Non-Hodgkin Lymphoma
The effect of CRM1 inhibition on human non-Hodgkin lymphoma cells
Primary B-cell Non-Hodgkin Lymphoma of Gallbladder Presenting as Cholecystitis
Bromodomain proteins as potential therapeutic targets for B-cell non-Hodgkin lymphoma
Non-coding RNA expression profiling of B-cell malignant (non-Hodgkin) lymphomas
Cytokine expression in B-cell non-Hodgkin lymphomas
Current immunotherapeutic approaches in T cell non-Hodgkin lymphomas
NHL-2007 - familial predisposition for non-Hodgkin lymphomas in childhood and adolescence
NHL-2007 - familial predisposition for non-Hodgkin lymphomas in childhood and adolescence
Harnessing natural killer cells for refractory/relapsed non-Hodgkin lymphoma: biological roles, clinical trials, and future prospective
Absence of annexin I expression in B-cell non-Hodgkin's lymphomas and cell lines
Advances in chimeric antigen receptor T-cell therapy for B-cell non-Hodgkin lymphoma
Front-Line Treatment of High Grade B Cell Non-Hodgkin Lymphoma
The effect of CRM1 inhibition on human non-Hodgkin lymphoma cells
Primary B-cell Non-Hodgkin Lymphoma of Gallbladder Presenting as Cholecystitis
Bromodomain proteins as potential therapeutic targets for B-cell non-Hodgkin lymphoma
Non-coding RNA expression profiling of B-cell malignant (non-Hodgkin) lymphomas
Cytokine expression in B-cell non-Hodgkin lymphomas
Current immunotherapeutic approaches in T cell non-Hodgkin lymphomas
NHL-2007 - familial predisposition for non-Hodgkin lymphomas in childhood and adolescence
NHL-2007 - familial predisposition for non-Hodgkin lymphomas in childhood and adolescence
Harnessing natural killer cells for refractory/relapsed non-Hodgkin lymphoma: biological roles, clinical trials, and future prospective
Absence of annexin I expression in B-cell non-Hodgkin's lymphomas and cell lines
Advances in chimeric antigen receptor T-cell therapy for B-cell non-Hodgkin lymphoma
Front-Line Treatment of High Grade B Cell Non-Hodgkin Lymphoma
The effect of CRM1 inhibition on human non-Hodgkin lymphoma cells
Primary B-cell Non-Hodgkin Lymphoma of Gallbladder Presenting as Cholecystitis
Bromodomain proteins as potential therapeutic targets for B-cell non-Hodgkin lymphoma